Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled study.
Journal: NPJ Parkinson's disease
Published: July 11, 2025
Intra-articular MM-II for the treatment of knee osteoarthritis pain: Efficacy and safety results from a 26-week, phase 2b, placebo-controlled, double-blind, randomized dose-ranging trial.
Journal: Osteoarthritis and cartilage
Published: September 30, 2024
Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trial.
Journal: The Lancet. Haematology
Published: July 19, 2024
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trial.
Journal: Journal of the American Academy of Dermatology
Published: June 24, 2024
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study.
Journal: Journal of the American Academy of Dermatology
Published: December 01, 2023
Response to: "Interleukin-23 Blockade Is Not Effective in Axial Spondyloarthritis".
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: September 07, 2023
A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study of Tildrakizumab Efficacy and Safety in Patients With Active Ankylosing Spondylitis.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: May 10, 2023
Plasma and cerebrospinal fluid pharmacokinetics of vodobatinib, a neuroprotective c-Abl tyrosine kinase inhibitor for the treatment of Parkinson's disease.
Journal: Parkinsonism & related disorders
Published: November 01, 2022
Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: A randomized controlled clinical trial.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 24, 2021
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.
Journal: Pediatric blood & cancer
Published: March 16, 2016
Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer.
Journal: JAMA internal medicine
Published: July 16, 2014
Last Updated: 09/26/2026